NCT00765674 - Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension | Biotech Hunter

Enrollment

1,191

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

Hypertension

Interventions

DRUG

Aliskiren

150 and 300 mg tablets

DRUG

Amlodipine

5 and 10 mg capsules

DRUG

Hydrochlorothiazide (HCTZ)

12.5 and 25 mg capsules

DRUG

Placebo

tablet

DRUG

Placebo

capsules

Trial Locations (12)

Investigative Site, Denver

Investigative Site, Sydney

Investigative Site, Ottawa

Investigative Site, Copenhagen

Investigative Site, Berlin

Investigative Site, Jerusalem

Investigative Site, Rome

Investigative Site, Riga

Investigative Site, Vilnius

Investigative Site, Bucharest

Investigative Site, Stockholm

Investigative Site, Ankara